ClinicalTrials.Veeva

Menu

A Multi-centre Evaluation of the Performance of Window Dressings on Subjects With High Risk Pressure Ulceration

Molnlycke Health Care logo

Molnlycke Health Care

Status and phase

Completed
Phase 4

Conditions

Pressure Ulcer

Treatments

Device: Window

Study type

Interventional

Funder types

Industry

Identifiers

NCT01438541
Window 02

Details and patient eligibility

About

This study will be conducted in approximately 26 subjects in UK to yield 20 evaluable subjects at 3 sites with approximately 5-10 subjects/site. Subjects with acute vascular, surgical and orthopaedic medical care in the elderly admission, with a high risk to develop skin breakdown or subjects with category 1 pressure ulcer can be enrolled in this investigation.

The rational for this study is to evaluate the potential for Window in the prevention of pressure ulcers because of its ability to reduce shear and friction forces.

Enrollment

29 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. acute vascular, surgical, orthopaedic, medical or care of the elderly admission

  2. aged 18 years or over

  3. have an expected total length of stay of 5 or more days

  4. at high risk of PU development due to one or more of the following

    • bedfast/chairfast AND completely immobile/very limited mobility
    • category 1 PU on any pressure area skin site (see appendix G)
  5. give their written, informed consent to participate

  6. expected to be able to comply with follow-up schedule

Exclusion criteria

  1. risk area which doesn't fit the dressing size 6*7cm, 10*12 cm and 15*20cm
  2. subject has category 2-4 pressure ulcer
  3. subject has documented skin disease at time of enrolment, as judged by the investigator
  4. known allergy/hypersensitivity to any of the components in the dressing
  5. previous enroled in the present study
  6. subject included in other ongoing clinical investigation at present, as judged by the investigator

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

29 participants in 1 patient group

Window
Experimental group
Description:
WindowTM is a protective layer that may reduce the shear and friction on the skin and may help to prevent skin breakdown. Window TM provides instant tack adhesion that minimizes the requirement of extra pressure in order to fixate well. The product does not leave residues and the adhesion level does not increase over time.
Treatment:
Device: Window

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems